FDA, under pressure from Trump, expected to authorize blood plasma as Covid-19 treatment

President Trump is expected to announce Sunday evening that the FDA will authorize the use of blood plasma from patients who have recovered from Covid-19 as a treatment for the disease. The decision could generate intense controversy inside the administration and the broader scientific community.